Aflatoxins, Hepatitis B Virus, and Hepatocellular Carcinoma

Research output: Contribution to journalLetter

6 Citations (Scopus)

Abstract

To the Editor: Blumberg and London clearly summarized the several lines of data that support the hypothesis that primary carcinoma is related to persistent infection with hepatitis B virus (HBV) (March 26 issue).1 However, they do not discuss the very high incidence of aflatoxin contamination of foods, which occurs in many of the same areas of the world where there is a high carriage rate of HBV.2 Aflatoxins (and other mycotoxins) may have a primary or secondary role in the development of primary hepatic carcinoma. They depress cellular immunity and thus may enhance a tendency toward persistent HBV infection, or.

Original languageEnglish (US)
Number of pages1
JournalNew England Journal of Medicine
Volume305
Issue number14
DOIs
StatePublished - Oct 1 1981

Fingerprint

Aflatoxin B1
Aflatoxins
Hepatitis B virus
Hepatocellular Carcinoma
Food Contamination
Carcinoma
Mycotoxins
Virus Diseases
Cellular Immunity
Liver
Incidence
Infection

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Aflatoxins, Hepatitis B Virus, and Hepatocellular Carcinoma. / Wray, Betty Beasley.

In: New England Journal of Medicine, Vol. 305, No. 14, 01.10.1981.

Research output: Contribution to journalLetter

@article{105451a5229f40fa906c5ade748b479b,
title = "Aflatoxins, Hepatitis B Virus, and Hepatocellular Carcinoma",
abstract = "To the Editor: Blumberg and London clearly summarized the several lines of data that support the hypothesis that primary carcinoma is related to persistent infection with hepatitis B virus (HBV) (March 26 issue).1 However, they do not discuss the very high incidence of aflatoxin contamination of foods, which occurs in many of the same areas of the world where there is a high carriage rate of HBV.2 Aflatoxins (and other mycotoxins) may have a primary or secondary role in the development of primary hepatic carcinoma. They depress cellular immunity and thus may enhance a tendency toward persistent HBV infection, or.",
author = "Wray, {Betty Beasley}",
year = "1981",
month = "10",
day = "1",
doi = "10.1056/NEJM198110013051416",
language = "English (US)",
volume = "305",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "14",

}

TY - JOUR

T1 - Aflatoxins, Hepatitis B Virus, and Hepatocellular Carcinoma

AU - Wray, Betty Beasley

PY - 1981/10/1

Y1 - 1981/10/1

N2 - To the Editor: Blumberg and London clearly summarized the several lines of data that support the hypothesis that primary carcinoma is related to persistent infection with hepatitis B virus (HBV) (March 26 issue).1 However, they do not discuss the very high incidence of aflatoxin contamination of foods, which occurs in many of the same areas of the world where there is a high carriage rate of HBV.2 Aflatoxins (and other mycotoxins) may have a primary or secondary role in the development of primary hepatic carcinoma. They depress cellular immunity and thus may enhance a tendency toward persistent HBV infection, or.

AB - To the Editor: Blumberg and London clearly summarized the several lines of data that support the hypothesis that primary carcinoma is related to persistent infection with hepatitis B virus (HBV) (March 26 issue).1 However, they do not discuss the very high incidence of aflatoxin contamination of foods, which occurs in many of the same areas of the world where there is a high carriage rate of HBV.2 Aflatoxins (and other mycotoxins) may have a primary or secondary role in the development of primary hepatic carcinoma. They depress cellular immunity and thus may enhance a tendency toward persistent HBV infection, or.

UR - http://www.scopus.com/inward/record.url?scp=0019484541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019484541&partnerID=8YFLogxK

U2 - 10.1056/NEJM198110013051416

DO - 10.1056/NEJM198110013051416

M3 - Letter

C2 - 6267468

AN - SCOPUS:0019484541

VL - 305

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 14

ER -